Skip to main content

Peer Review reports

From: Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report

Original Submission
19 Feb 2021 Submitted Original manuscript
14 Mar 2021 Reviewed Reviewer Report - nurashikin mohammad
2 Jun 2021 Reviewed Reviewer Report - ARAVIND PONNUSWAMY
17 Jun 2021 Author responded Author comments - Lander Van Acker
Resubmission - Version 2
17 Jun 2021 Submitted Manuscript version 2
25 Jun 2021 Reviewed Reviewer Report - ARAVIND PONNUSWAMY
29 Jun 2021 Reviewed Reviewer Report - nurashikin mohammad
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
1 Jul 2021 Editorially accepted
22 Nov 2021 Article published 10.1186/s13256-021-02994-0

You can find further information about peer review here.

Back to article page